These 4 drugs had tons of promise — and they flopped. What happened?

1. Huge controversies that cling to a drug can kill it — and kill it quickly.

2. Showing up with a cure doesn’t mean a company will be able to successfully commercialize it.

3. Safety problems combined with middling efficacy aren’t worth the risk for patients or regulators.

4. Rigorous treatment regimens can sink even the most promising drugs, especially during a global pandemic.

Discover these 4 flops and maybe learn how to avoid it HERE (Pharmavoice)